Florida-based private equity firm Accelmed Partners closed its second fund at its hard cap of $400 million, with a unique focus on lower middle market healthcare technology companies . . .
Continue Reading With a Free Trial
Unlock this article instantly, along with the rest of our premium content, newsletters and mandate charts.
Already a subscriber? Log in.